Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.1100 (-3.55%) ($9.1100 - $9.1100) on Fri. Feb. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.72% (three month average) | RSI | 35 | Latest Price | $9.1100(-3.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(29%) IBB(26%) SDY(26%) XLRE(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.86% in a week (0% probabilities). VIXM(-15%) UUP(-9%) VXX(-7%) SMH(-2%) TBT(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.86% (StdDev 3.72%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.34(-103.73%) | Resistance Level | $10.12 | 5 Day Moving Average | $9.41(-3.19%) | 10 Day Moving Average | $9.78(-6.85%) | 20 Day Moving Average | $10.12(-9.98%) | To recent high | -32% | To recent low | 4.8% | Market Cap | $1.607b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |